Proton Collaborative Group
Proton Collaborative Group is a private, small-scale clinical research organization founded in 2009 that coordinates multi-center proton therapy trials, manages trial memberships, and maintains proton therapy outcomes data across participating treatment centers.
- Company typePrivate
- Founded2009
- HeadquartersWarrenville, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Proton Collaborative Group does
Proton Collaborative Group (PCG) is a privately held research organization founded in 2009 and headquartered in Warrenville, Illinois. According to the firmographic record, PCG coordinates multi-center proton therapy clinical research, manages trial memberships, and maintains a proton therapy outcomes data registry spanning participating treatment centers. The organization operates with a small staff of 1–10 employees, consistent with a focused clinical research consortium rather than a commercial enterprise.
PCG's business model appears to be that of an institutional research collaborative. Its stated activities — multi-center trial coordination, membership administration, and outcomes data aggregation — are typical of consortia that derive operating support from member site dues, per-study fees, and grant funding. The input data does not disclose a pricing model, GTM motion, customer list, or revenue figures, and the corporate website (pcgresearch.org) is currently returning only a verification/loader page with no substantive content.
The available data is materially thin. No management team, board, funding rounds, partnerships, products, patents, certifications, M&A activity, or product launches are documented. As a result, several standard diligence dimensions — unit economics, member retention, competitive positioning versus other proton therapy research groups (e.g., the Proton Therapy Cooperative Oncology Group), AI/technology stack, and revenue concentration — cannot be assessed from the current source set.
Proton Collaborative Group firmographics
Firmographics- Name
- Proton Collaborative Group
- Website
- https://pcgresearch.org
- Company type
- Private
- Founded year
- 2009
- Headcount range
- 1–10 employees
- Short description
- Proton Collaborative Group is a private, small-scale clinical research organization founded in 2009 that coordinates multi-center proton therapy trials, manages trial memberships, and maintains proton therapy outcomes data across participating treatment centers.
- Ownership category
- akta.pro rank
Proton Collaborative Group industry classification
Industry- Product category
- Clinical Research Services
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Membership Organizations (8600)
- akta.pro primary industry
- Clinical Trial Site Operations & Study Coordination (HLAGACAE)
- akta.pro secondary industry
- Nuclear Medicine Clinical Services & Therapy Centers (HLAIAGAI)
Keywords
Where Proton Collaborative Group is headquartered
LocationHeadquarters
- HQ city
- Warrenville
- HQ country
- United States
- HQ region
- North America
Markets served
Proton Collaborative Group business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D
Proton Collaborative Group product offering
Product offeringCore offering
Proton Collaborative Group coordinates multi-center proton therapy clinical research, manages trial memberships, and maintains a proton therapy outcomes data registry. The organization facilitates collaborative oncology research across participating treatment centers.
Differentiator
Problem solved
Functional benefit
Products and services
- Multi-center Proton Therapy Clinical Research Centralized coordination of proton therapy clinical trials across multiple participating cancer treatment centers, enabling collaborative radiation oncology research that individual centers could not conduct independently.
- Proton Therapy Outcomes Data Registry A centralized outcomes data registry collecting proton therapy treatment results from member institutions to support research and benchmarking across the proton therapy community.
- Trial Membership Program A membership program through which cancer treatment centers and proton therapy facilities join the collaborative group and participate in coordinated clinical trials.
Companies that use Proton Collaborative Group
Customer profileIdeal customer profiles1 record
Proton Collaborative Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Proton Collaborative Group competitors and assessment
Company assessmentDirect peers
- Particle Therapy Co-Operative Group (PTCOG): International scientific organization dedicated to particle therapy (protons, carbon ions). Closely comparable as a proton/particle therapy-focused consortium that brings together centers, clinicians, and researchers to advance trial activity and clinical evidence.
- NRG Oncology: A large NCI-funded cooperative group that runs multi-center radiation oncology (including proton) clinical trials. Directly comparable as a multi-institutional oncology research consortium coordinating radiation therapy trials across member sites.
Regional players
- Procure: Proton therapy center operator with significant clinical research activity. Comparable as a proton-therapy focused organization contributing to clinical evidence, though primarily a treatment provider rather than a coordinating consortium.
Emerging players
- Children's Oncology Group: Largest pediatric cancer research cooperative, runs many proton therapy trials in pediatric populations. Comparable as a multi-center oncology research consortium with significant overlap in proton therapy trial activity.
Broad incumbents
- Alliance for Clinical Trials in Oncology: NCI-funded cooperative group conducting multi-center oncology trials. Comparable as a large-scale, multi-institutional oncology research consortium, though not specialized to proton therapy.
- ECOG-ACRIN Cancer Research Group: Large NCI-sponsored cooperative group running multi-center oncology trials including radiation modalities. Comparable as a multi-center oncology trial coordinator, though much broader in scope than a proton-focused group.
Others
- Mevion Medical Systems: Manufacturer of compact proton therapy systems. Comparable as an ecosystem participant in the proton therapy space that relies on clinical evidence to support adoption — a likely sponsor/partner counterpart for the consortium.
- IROC (Imaging and Radiation Oncology Core): NIH/NCI-funded core that provides radiation therapy and imaging quality assurance for multi-center trials. Comparable as an enabling infrastructure provider supporting site-level credentialing and data quality for radiation oncology trials.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat3 records
Key risks5 records
Key highlights3 records
Customer concentration
Proton Collaborative Group social profiles
Digital presenceProton Collaborative Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Proton Collaborative Group leadership team
Management profileNumber of profiles
Proton Collaborative Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Proton Collaborative Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Proton Collaborative Group
What does Proton Collaborative Group do?
Proton Collaborative Group coordinates multi-center proton therapy clinical research, manages trial memberships, and maintains a proton therapy outcomes data registry. The organization facilitates collaborative oncology research across participating treatment centers.
When was Proton Collaborative Group founded?
Proton Collaborative Group was founded in 2009. It employs 1 to 10 people.
Where is Proton Collaborative Group based?
Proton Collaborative Group is headquartered in Warrenville, United States, in the North America region.
Who are Proton Collaborative Group's main competitors?
Direct peers on record are Particle Therapy Co-Operative Group (PTCOG) and NRG Oncology. Procure is listed as a regional player. Children's Oncology Group is listed as an emerging player. Broad incumbents are Alliance for Clinical Trials in Oncology and ECOG-ACRIN Cancer Research Group. Others are Mevion Medical Systems and IROC (Imaging and Radiation Oncology Core).
Does Proton Collaborative Group have an API?
No public API is recorded for Proton Collaborative Group.
What industry is Proton Collaborative Group in?
Proton Collaborative Group's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAIAGAI, Nuclear Medicine Clinical Services & Therapy Centers. Its SIC code is 8731.